Evidence map›Paper›PMID 42350373›Full record

ArticleNature communications2026

Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.

Rebecca Casterton, Aitana Martinez-Cotrina, Jodi Barnard, Eleanor Wycherley, Yanling Hu, Rhys Anderson, Sebastien Janel, Jiin Byun, Olivia Houghton, Daniel A Solomon and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rebecca CastertonDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Aitana Martinez-CotrinaDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Jodi BarnardDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.ORCID 0009-0001-6774-6478
Eleanor WycherleyDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Yanling HuDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Rhys AndersonGuy's & St. Thomas' Hospital NHS Foundation Trust, London, UK.
Sebastien JanelUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.ORCID 0000-0001-6736-3162
Jiin ByunCollege of Pharmacy, The Catholic University of Korea, Seoul, Republic of Korea.
Olivia HoughtonDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Daniel A SolomonDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.
Juan AlcaldeDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.ORCID 0000-0002-7959-6876
Frank LafontUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
Marc-David RueppDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.ORCID 0000-0003-3264-9800
Frank HirthDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.ORCID 0000-0001-8581-9450
Bart TummersCentre for Inflammation Biology and Cancer Immunology, King's College London, London, UK.ORCID 0000-0001-7580-778X
Yong-Yeon ChoCollege of Pharmacy, The Catholic University of Korea, Seoul, Republic of Korea.ORCID 0000-0003-1107-2651
Gian De NicolaRandall Division of Cell and Molecular Biophysics, King's College London, London, UK.ORCID 0000-0003-4649-9452
Sarah MizielinskaDepartment of Basic and Clinical Neuroscience, King's College London, London, UK.ORCID 0000-0001-8052-600X
Manolis FantoDepartment of Basic and Clinical Neuroscience, King's College London, London, UK. manolis.fanto@kcl.ac.uk.ORCID 0000-0001-7807-2563

Funding

Alzheimer's Research UK (ARUK) ARUK-PG2019B-008
6 · The paper itself

Abstract

Neurodegenerative diseases are frequently associated with proteotoxic stress linked to disease specific proteins. The autophagy-lysosome system provides essential control of proteotoxic stress and its failure can lead to initiation of apoptosis. However, in aging and neurodegenerative diseases apoptosis is insufficient to account for all neuronal death, and several different cell death types have been reported in these contexts. Here we show that karyoptosis, a distinct form of cell death, can be induced by proteotoxic stress and then develops through nuclear degeneration and cellular expulsion of nuclear material. We establish that karyoptosis is regulated by the p38 kinase signalling pathway, which controls stability of the nuclear lamina protein LaminB1 via direct phosphorylation. We demonstrate that karyoptosis affects neurons in models of amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) pathology. Finally, we identify karyoptotic features in post-mortem frontal cortex of FTD and Alzheimer's disease (AD) patients. Together these findings characterise a form of cell death directly linked to proteotoxic stress and nuclear lamina stability that is associated with neurodegeneration.

Indexed as

Neurodegenerative DiseasesAlzheimer DiseaseAnimalsCell DeathCell NucleusFrontotemporal DementiaHumansLamin Type BMiceNeuronsNuclear Laminap38 Mitogen-Activated Protein KinasesPhosphorylationProteotoxic StressLamin Type Bp38 Mitogen-Activated Protein Kinases

Identifiers

PMID42350373
PMCPMC13303863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.